Hepatology

The number one unmet need is that we don’t have a good handle on who’s at risk, because patients generally don’t have too many symptoms

EMJ is thrilled to present an interview with Massimo Colombo, Past Professor of Gastroenterology at the University of Milan, Italy, that…

Progressive familial intrahepatic cholestasis (PFIC) is a cholestatic condition that typically arises in childhood. As such, if an adult…

For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…

The management of liver cancer has changed dramatically during the 4 decades since I started as an internal medicine speciality fellow…

Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…

Zinc salts are one of three approved treatments for the autosomal recessive condition Wilson’s disease (WD). Their use was first described…

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…